169
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Disseminated Strongyloidiasis Misdiagnosed as Guillain-Barré Syndrome: The Value of High-Throughput Genetic Sequencing of Pathogenic Microorganisms in Parasitic Infections

ORCID Icon, , , , &
Pages 5601-5607 | Received 27 Jul 2022, Accepted 12 Sep 2022, Published online: 22 Sep 2022

References

  • Palmeirim MS, Hürlimann E, Knopp S, et al. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: a systematic review meta-analysis and individual patient data analysis. PLoS Negl Trop Dis. 2018;12(4):e0006458. doi:10.1371/journal.pntd.0006458
  • Zibaei M, Nosrati MRC, Shadnoosh F, et al. Insights into hookworm prevalence in Asia: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2020;114(3):141–154. doi:10.1093/trstmh/trz115
  • Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7(7):e2288. doi:10.1371/journal.pntd.0002288
  • Gonzalez-Ibarra F, Chevli P, Schachter L, et al. Strongyloidiasis and diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. Case Rep Med. 2014;2014:278390. doi:10.1155/2014/278390
  • Beknazarova M, Whiley H, Ross K. Strongyloidiasis: a disease of socioeconomic disadvantage. Int J Environ Res Public Health. 2016;13(5):517. doi:10.3390/ijerph13050517
  • Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367(9521):1521–1532. doi:10.1016/S0140-6736(06)68653-4
  • Lim S, Katz K, Krajden S, et al. Complicated and fatal Strongyloides stercoralis infection in Canadians: risk factors, diagnosis and management. CMAJ. 2004;171:479–484. doi:10.1503/cmaj.1031698
  • Paula FM, Costa-Cruz JM. Epidemiological aspects of strongyloidiasis in Brazil. Parasitology. 2011;138:1331–1340. doi:10.1017/S003118201100120X
  • Wang C, Xu J, Zhou X, et al. Strongyloidiasis: an emerging infectious disease in China. Am J Trop Med Hyg. 2013;88(3):420–425. doi:10.4269/ajtmh.12-0596
  • Guo JD, Zhao LL. Strongyloides stercoralis investigation among population at Yellow River flood area in the lower Yellow River [in Chinese]. Chin J Parasitic Dis Contr. 2005;18:2–4.
  • Lagacé-Wiens PR, Harding GKA. Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1. CMAJ. 2007;177:451–453. doi:10.1503/cmaj.070126
  • Arifin N, Hanafiah KM, Ahmad H, Noordin R. Serodiagnosis and early detection of Strongyloides stercoralis infection. J Microbiol Immunol Infect. 2019;52:371–378. doi:10.1016/j.jmii.2018.10.001
  • Buonfrate D, Requena-Mendez A, Angheben A, et al. Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection-A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12:e0006229. doi:10.1371/journal.pntd.0006229
  • Qian YY, Wang HY, Zhou Y, et al. Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing. Front Cell Infect Microbiol. 2021;10:567615.
  • Chen P, Sun W, He Y. Comparison of metagenomic next-generation sequencing technology, culture and GeneXpert MTB/RIF assay in the diagnosis of tuberculosis. J Thorac Dis. 2020;12:4014–4024. doi:10.21037/jtd-20-1232
  • Huang H, Deng J, Qin C, et al. Disseminated Coinfection by Mycobacterium fortuitum and Talaromyces marneffei in a Non-HIV Case. Infect Drug Resist. 2021;14:3619–3625. doi:10.2147/IDR.S316881
  • Qu J, Zong Z. Strongyloidiasis in a patient diagnosed by metagenomic next-generation sequencing: a case report. Front Med. 2022;9:835252. doi:10.3389/fmed.2022.835252
  • Boggild AK, Libman M, Greenaway C, et al. CATMAT statement on disseminated strongyloidiasis: prevention, assessment and management guidelines. Can Commun Dis Rep. 2016;42(1):12–19. doi:10.14745/ccdr.v42i01a03
  • Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;1:CD007745.
  • Singer R, Sarkar S. Modeling strongyloidiasis risk in the United States. Int J Infect Dis. 2020;100:366–372. doi:10.1016/j.ijid.2020.09.002